Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
●European Group for Blood and Marrow Transplantation (EBMT): Best practice recommendations for allogeneic haematopoietic cell transplantation for myelofibrosis – Proposed definitions and management strategies for graft failure, poor graft function and relapse (2021)
●British Society for Haematology (BSH): Good practice paper on the use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders (2021)
●British Committee for Standards in Haematology (BCSH): Use of JAK inhibitors in the management of myelofibrosis – A revision of the guidelines for investigation and management of myelofibrosis, 2012 (published 2014)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟